A new type of mRNA vaccine is more adaptable to mutating viruses like SARS-CoV-2 and the bird flu, according to research from ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

Researchers have developed a new mRNA vaccine that overcomes the challenges associated with current mRNA therapeutic ...

Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable ...

A team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1.

The study was published today in npj Vaccines, an open-access scientific journal that is part of the Nature Portfolio. "Malaria elimination will not happen overnight but such vaccines could ...

The study, recently published in the Nature journal npj Vaccines, was led by Prof. Michael Edelstein, of Bar-Ilan University's Azrieli Faculty of Medicine, in cooperation with infectious disease ...

“Tropis complements the GEMCOVAC-OM booster vaccine by easily leveraging the rich network of dendritic cells, macrophages, and T cells in the dermal layer providing a more potent and broader ...

npj Vaccines is part of the npj Series: open access community journals from Nature Portfolio publishing high-quality research, reviews and commentary across the life, health, physical, applied and ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.

The study was published today in npj Vaccines. Though highly effective at inducing an immune response, current mRNA vaccines, such as those used to prevent COVID-19, present two significant ...